Kirill Peskov

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Crystal Structure

Anti Inflammatory Drugs

Top Venues

CPT: pharmacometrics & systems pharmacology

Diabetes, obesity & metabolism

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Victoria Kulesh, Igor Vasyutin, Alina Volkova, Kirill Peskov, Holly Kimko, Victor Sokolov, Ravindra Alluri
A tutorial for model-based evaluation and translation of cardiovascular safety in preclinical trials. CPT: pharmacometrics & systems pharmacology (2023)
Alexey N Goltsov, Maciej Swat, Kirill Peskov, Yuri Kosinsky
Cycle Network Model of Prostaglandin H Synthase-1. Pharmaceuticals (Basel, Switzerland) 13 (10) (2020)
Boris Shulgin, Yuri Kosinsky, Andrey Omelchenko, Lulu Chu, Ganesh Mugundu, Sergey Aksenov, Rodrigo Pimentel, Garrett DeYulia, Geoffrey Kim, Kirill Peskov, Gabriel Helmlinger
Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis. Oncoimmunology 9 (1) (2020)
Tatiana Yakovleva, Victor Sokolov, Lulu Chu, Weifeng Tang, Peter J Greasley, Helena Peilot Sjögren, Susanne Johansson, Kirill Peskov, Gabriel Helmlinger, David W Boulton, Robert C Penland
Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors. Diabetes, obesity & metabolism 21 (12) (2019)